Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
FEBS Letters|November 6, 1998
Loss of imprinting of IGF2 and not H19 in breast cancer, adjacent normal tissue and derived fibroblast culturesC E van Roozendaal, A J Gillis, J G Klijn, et al.
International Journal of Obesity (2005)|January 26, 2021
A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patientsEmma J Kooistra, Aline H de Nooijer, Wout J Claassen, et al.
Neurology|July 8, 2011
A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxiasM Strupp, R Kalla, J Claassen, et al.
Brain Pathology (Zurich, Switzerland)|May 19, 2024
Decreased microvascular claudin-5 levels in cerebral amyloid angiopathy associated with intracerebral haemorrhageLieke Jäkel, Kiki K W J Claassen, Anna M De Kort, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|September 12, 2020
Clinical and advanced neurophysiology in the prognostic and diagnostic evaluation of disorders of consciousness: review of an IFCN-endorsed expert groupA Comanducci, M Boly, J Claassen, et al.
Journal of Cachexia, Sarcopenia and Muscle|February 16, 2026
Loss of Myonuclei and Transcriptional Activity During Diaphragm Atrophy in Critically Ill PatientsWout J Claassen, Marloes van den Berg, Zhong Hua Shi, et al.
Intensive Care Medicine Experimental|June 3, 2025
In vitro and in vivo muscle mass and strength during the first week of critical illnessWout J Claassen, Isabel M van Ruijven, Marloes van den Berg, et al.
Cancer Research|April 29, 2000
Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancerE M Berns, J A Foekens, R Vossen, et al.
Pageof 8